This quarter we look at interesting off-target activity of some drug metabolites, using the metabolism of valsartan to 4-hydroxyvaleryl-valsartan as a case study.
Click here for a pdf of the newsletter.
This quarter we look at interesting off-target activity of some drug metabolites, using the metabolism of valsartan to 4-hydroxyvaleryl-valsartan as a case study.
Click here for a pdf of the newsletter.
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.
Cookie Policy | Privacy Policy | Website Terms and Conditions
© Hypha Discovery 2021. All Rights Reserved. Website by Fifteen.co.uk